Analysis of tumor necrosis factor-α, lymphotoxin-α, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis

American Journal of Respiratory and Critical Care Medicine

Volumn 163, Issue 6, 2001, Pages 1432-1436

  Pantelidis, P ^a   Fanning, G C ^a   Wells, A U ^a   Welsh, K I ^a   Du Bois, R M ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ALLELE; ARTICLE; CARBON DIOXIDE TRANSPORT; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DISEASE CARRIER; DISEASE COURSE; DYSPNEA; FEMALE; GENE FREQUENCY; GENE LOCATION; GENETIC ANALYSIS; GENETIC CODE; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; INFLAMMATION; INTRON; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; MARKER GENE; PRIORITY JOURNAL;

EID: 0034993072     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.163.6.2006064     Document Type: Article

References (31)

1. TNF and IL-6 mediate MIP-1alpha expression in bleomycin-induced lung injury
2. Expression and localization of tumor necrosis factor-alpha and its mRNA in idiopathic pulmonary fibrosis
3. Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica
4. Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis
5. Is there a fibrotic gene?
6. Familial idiopathic pulmonary fibrosis: Evidence of lung inflammation in unaffected family members
7. TNF-alpha receptor knockout mice are protected from the fibroproliferative effects of inhaled asbestos fibers
8. Upregulation of the p75 but not the p55 TNF-alpha receptor mRNA after silica and bleomycin exposure and protection from lung injury in double receptor knockout mice
9. Expression of tumour necrosis factor-alpha in cryptogenic fibrosing alveolitis
10. Expression and localization of tumor necrosis factor-alpha and its mRNA in idiopathic pulmonary fibrosis
11. Enhanced IL-1 beta and tumor necrosis factor-alpha release and messenger RNA expression in macrophages from idiopathic pulmonary fibrosis or after asbestos exposure
12. Expression of a tumor necrosis factor-alpha transgene in murine lung causes lymphocytic and fibrosing alveolitis: A mouse model of progressive pulmonary fibrosis
13. Genetic influence on cytokine production and fatal meningococcal disease
14. Resistance of TNF/LT alpha double deficient mice to bleomycin-induced fibrosis
15. Persistent interleukin-2 activity and molecular evidence for expression of lymphotoxin in the hapten-immune model for pulmonary interstitial fibrosis
16. Cytokine (TNFα, LTα and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: Differential effects on production and allele frequencies
17. Measurement of interleukin-6 in bronchoalveolar lavage fluid by radioimmunoassay: Differences between patients with interstitial lung disease and control subjects
18. IL-6 and IL-1 beta in fever: Studies using cytokine-deficient (knockout) mice
19. IL-6 and IL-6 receptor modulation by IFN-gamma and tumor necrosis factor-alpha in human monocytic cell line (THP-1): Priming effect of IFN-gamma
20. p55 and p75 tumor necrosis factor receptors are expressed and mediate common functions in synovial fibroblasts and other fibroblasts
21. Increased IL-6 and IL-8 in bronchoalveolar lavage fluids (BALF) from patients with sarcoidosis: Correlation with the clinical parameters
22. PCR analysis of cytokine induction profiles associated with mouse strain variation in susceptibility to pulmonary fibrosis
23. Polymorphic analysis of the high-affinity tumor necrosis factor receptor 2
24. Polymerase chain reaction haplotyping using 3′ mismatches in the forward and reverse primers: Application to the biallelic polymorphisms of tumor necrosis factor and lymphotoxin alpha
25. Is interleukin-6 important in inflammatory bowel disease?
26. Phototyping-comprehensive DNA typing for HLA-A, HLA-B, HLA-C, DRB1, DRB3, DRB4, DRB5 and DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP)
27. TNFα, LT alpha and TNF-RII polymorphisms in systemic sclerosis: Associations with clinical subgroup, pulmonary fibrosis and raised creatinine kinase levels
28. Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms
29. HLA-DRB1*03, but not the TNFA -308 promoter gene polymorphism, confers protection against fistulising Crohn's disease
30. Polymorphism of the human TNF-alpha promoter - Random variation or functional diversity?
31. A polymorphism in the interleukin-6 (IL-6) gene conferring high IL-6 production is associated with systemic-onset jca